SCHEMBL8907356

SCHEMBL8907356

CC(C=O)OC1CCOCC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8458686 1.00 PIK3CD (0.31) PIK3CD
SCHEMBL8891955 0.88 PDE4D (0.32)
SCHEMBL29224347 0.84
SCHEMBL10750623 0.84
SCHEMBL30142081 0.78 ADH1C (0.38)
SCHEMBL3821465 0.77 ACACB (0.32)
SCHEMBL7453924 0.77 ACACB (0.32)
SCHEMBL8925039 0.76 PIK3CD (0.33) PIK3CD
SCHEMBL737520 0.75 PIK3CD (0.35) PIK3CD
SCHEMBL29832906 0.73 CHRM1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763041-A1 INDOLOCARBAZOLE DERIVATIVES FOR SENSITIZING MULTIDRUG-RESISTANT CELLS TO ANTITUMOR AGENTS Novartis AG (CH) 1997-03-19 EP claimed
WO-1995032975-A1 INDOLOCARBAZOLE DERIVATIVES FOR SENSITIZING MULTIDRUG-RESISTANT CELLS TO ANTITUMOR AGENTS CIBA-GEIGY AG (CH) 1995-12-07 WO claimed
EP-0763041-A1 INDOLOCARBAZOLE DERIVATIVES FOR SENSITIZING MULTIDRUG-RESISTANT CELLS TO ANTITUMOR AGENTS Novartis AG (CH) 1997-03-19 EP disclosed
WO-1995032975-A1 INDOLOCARBAZOLE DERIVATIVES FOR SENSITIZING MULTIDRUG-RESISTANT CELLS TO ANTITUMOR AGENTS CIBA-GEIGY AG (CH) 1995-12-07 WO disclosed